The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis-Reference-Cited by-同舟云学术

The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

Published:2019-12-19 Issue:1 Volume:19 Page:69-82
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Zabotti Alen¹,Goletti Delia²^ORCID,Lubrano Ennio³,Cantini Fabrizio⁴

Affiliation:

1. Department of Medical and Biological Sciences, Rheumatology Clinic, University of Udine, Udine, Italy

2. Translational Research Unit, Epidemiology and Preclinical Research Department, National Institute for Infectious Diseases Lazzaro Spallanzani–IRCCS, Rome, Italy

3. Dipartimento di Medicina e Scienze della Salute “Vincenzo Tiberio”, Università degli Studi del Molise, Campobasso, Italy

4. Department of Rheumatology, Hospital of Prato, Prato, Italy

Funder

Janssen

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1703946

Reference105 articles.

1. Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?

2. Psoriatic Arthritis

3. Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies

4. Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis

5. Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: Usefulness of administrative data

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN‐FRT expert consensus;Journal of the European Academy of Dermatology and Venereology;2024-08-16

2. The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis;Reumatismo;2023-03-21

3. IL-12p40 deletion aggravates lipopolysaccharide-induced cardiac dysfunction in mice;Frontiers in Cardiovascular Medicine;2022-09-16

4. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies;Gastroenterología y Hepatología (English Edition);2021-10

5. Riesgo de infección asociado a los inhibidores de las quinasas Janus (JAK) y las terapias biológicas en enfermedad inflamatoria intestinal y artritis reumatoide. Estrategias de prevención;Gastroenterología y Hepatología;2021-10